Home/Filings/4/0002063633-25-000004
4//SEC Filing

Pauling David 4

Accession 0002063633-25-000004

CIK 0001382101other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 8:14 AM ET

Size

5.0 KB

Accession

0002063633-25-000004

Insider Transaction Report

Form 4
Period: 2025-10-15
Pauling David
Chief Admin. Ofcr. & GC
Transactions
  • Purchase

    Common Stock

    2025-10-15$0.80/sh+12,504$9,99371,737 total
Footnotes (1)
  • [F1]The reported total includes 2,500 shares of Common Stock acquired by the reporting person in one or more transactions with the Issuer pursuant to its Employee Stock Purchase Plan, which transactions are exempt pursuant to Rules 16a3(f)(1)(i)(B) and 16b3(c).

Issuer

SUTRO BIOPHARMA, INC.

CIK 0001382101

Entity typeother

Related Parties

1
  • filerCIK 0002063633

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 8:14 AM ET
Size
5.0 KB